More Globe Newswire

View Older Stories View Newer Stories

Apr 3, 2025 04:00AM Share Buyback Transaction Details March 27 – April 2, 2025
Apr 3, 2025 04:00AM Axi launches ‘Four Years’ campaign with Manchester City stars
Apr 3, 2025 04:00AM Free Global Cities: A New Vision for Turning the Migration Crisis into an Opportunity
Apr 3, 2025 04:00AM big xyt Announces Formal Bid for European Consolidated Tape Provider with Widespread Industry Support
Apr 3, 2025 03:07AM Walker Lane Resources Ltd. Notes Unusual Trading Activity and the Development of its New Website
Apr 3, 2025 03:01AM Riyadh Air Selects Viasat to Power Full, Fast, Free Streaming Connectivity on Boeing 787 Dreamliner Aircraft
Apr 3, 2025 03:00AM Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
Apr 3, 2025 03:00AM Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
Apr 3, 2025 03:00AM Municipality Finance issues EUR 25 million notes under its MTN programme
Apr 3, 2025 03:00AM Offentliggørelse af prospekter, Investeringsforeningen Wealth Invest
Apr 3, 2025 02:45AM BW Offshore: Arbitration settlement
Apr 3, 2025 02:30AM Valeo - voting rights March 2025
Apr 3, 2025 02:15AM Stolt-Nielsen Limited Announces Intention to Relaunch Share Buy-Back Programme
Apr 3, 2025 02:15AM URW announces the successful results of the tender offer on its NC2028 Hybrid Notes
Apr 3, 2025 02:08AM Scandinavian Tobacco Group A/S: Financial Calendar 2025
Apr 3, 2025 02:01AM Diversified Energy Demonstrates Innovation, Collaboration, and Responsibility in 2024 Sustainability Report
Apr 3, 2025 02:00AM Novo Nordisk announces changes in Executive Management
Apr 3, 2025 02:00AM Welcome, Future. ELUXEO® 8000 Endoscopy System
Apr 3, 2025 02:00AM FORM 8.1(c) & (d)(i)
Apr 3, 2025 02:00AM Stolt-Nielsen Limited Reports Unaudited Results For the First Quarter of 2025
Apr 3, 2025 02:00AM Rule 2.12 Announcement
Apr 3, 2025 02:00AM Director/PDMR Shareholding
Apr 3, 2025 02:00AM Completion of Share Buyback Programme
Apr 3, 2025 02:00AM LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
Apr 3, 2025 02:00AM Notice of Annual General Meeting of Scatec ASA
Apr 3, 2025 02:00AM Commercial electric vehicles are in demand in China – Feintool participates with important e-motor core order
Apr 3, 2025 02:00AM AS Tallink Grupp Statistics for March and the First Quarter of 2025
Apr 3, 2025 02:00AM 2024 Annual Report of Arco Vara
Apr 3, 2025 01:30AM Transaction in Own Shares
Apr 3, 2025 01:02AM Adoption of the decisions of AS PRFoods noteholders by written procedure
Apr 3, 2025 01:01AM Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam
Apr 3, 2025 01:00AM Tyton Partners and Ufi Ventures Release 2025 Annual VocTech Market Report: Policy Inflection, Skills Gaps, and AI Transformations Define the Future of Workforce Development
Apr 3, 2025 01:00AM Start of Day Message
Apr 3, 2025 01:00AM DNO Releases 2024 Annual Report and Accounts
Apr 3, 2025 01:00AM Pharming Group announces the filing of its 2024 Annual Report and Form 20-F
Apr 3, 2025 01:00AM SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT
Apr 3, 2025 01:00AM Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
Apr 3, 2025 01:00AM PROPOSAL FOR ADOPTION OF RESOLUTIONS OF SHAREHOLDERS´ GENERAL MEETING OF PRFOODS WITHOUT CONVENING A MEETING
Apr 3, 2025 01:00AM dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%
Apr 3, 2025 01:00AM Tallinna Sadam audited Annual Report 2024 and dividend proposal
Apr 3, 2025 01:00AM Kitron: Notice of Annual General Meeting on 24 April 2025 at 11:00 a.m. CEST
Apr 3, 2025 01:00AM Veteran Banker Joins Avextra’s Supervisory Board 
Apr 2, 2025 09:11PM Domenico Carosa Files Early Warning Report with Respect to Common Shares of Banxa Holdings Inc.
Apr 2, 2025 08:13PM Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)
Apr 2, 2025 08:05PM Crushon AI Adds Target Play for Spicy AI and NSFW Character Chats
Apr 2, 2025 08:05PM CAPREIT Announces Over $560 Million in Additional Dispositions in Europe
Apr 2, 2025 08:00PM HYTN Receives GMP Certificates for The United States, Bermuda and Israel
Apr 2, 2025 08:00PM RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
Apr 2, 2025 07:27PM ERES Announces a Further €362 Million in Strategic Dispositions
Apr 2, 2025 07:15PM Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure
View Newer Stories View Older Stories